2
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
47
Polycystic Ovary Syndrome
6
Infertility
2
Hyperandrogenism
2
Stage I Prostate Adenocarcinoma AJCC v7
1
Sexual Dysfunction, Physiological
1
Prostatic Intraepithelial Neoplasia
1
Prostate Adenocarcinoma
1
Primary Dysautonomias
1
Overweight
1
Ovarian Neoplasms
1
Oligomenorrhea
1
Neoplasm Metastasis
1
Metabolic Syndrome
1
Kidney Diseases
1
Insulin Resistance
1
Hypertension
1
Hirsutism
1
Castration-resistant Prostate Cancer
1
Carcinoma, Ovarian Epithelial
1
Anovulation
1
Amenorrhea
1
Adenocarcinoma
1
Interventions
Toremifene
2
Lycopene
2
Sugars
1
Minerals
1
Geritol
1
Flutamide
1
Finasteride
1
Dietary Supplements
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Intraepithelial Neoplasia
×
Flutamide
×
Clear all
NCT06601205
2024-09-19
2F
Ente Ospedaliero Ospedali Galliera
Phase 2/3
Completed
125 enrolled